TSE:7508 stock news
This page provides real-time market news, earnings updates, and company announcements related to G-7 Holdings Inc. (TSE:7508).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 07:51 JST
Lenovo held a tech gala at the Sphere, showcasing both foldable phones and foldable computers | CES
爱范儿2026-01-08 03:39:29
‘Humans might follow the path of horses’: Goldman assessed the potential severity of the AI-driven ‘job apocalypse’—and its experts found the results unexpectedly reassuring
101 finance2026-01-13 20:45:31
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Finviz2026-02-12 21:09:36
Westwood Holdings Group Reports Fourth Quarter and Full Year 2025 Results
Finviz2026-02-13 21:12:11
Etsy Q4 2025 Earnings Call Transcript
Finviz2026-02-19 16:48:40
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers
Finviz2026-02-20 12:06:46
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Finviz2026-02-23 21:09:10
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Finviz2026-02-24 12:03:57
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
Finviz2026-02-25 12:10:04
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
Finviz2026-02-25 13:03:47
Compared to Projections, The Williams Companies (WMB) Q4 Results: Examining Important Performance Indicators
101 finance2026-02-25 15:34:10
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-26 12:03:47
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
Finviz2026-02-26 12:03:46
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Finviz2026-02-26 21:09:39
Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Finviz2026-02-26 21:06:42
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:09:43
Diversified Energy Reports Record Year, Highlighted by Transformative Year-over-Year Growth, Strong Cash Generation, and Integration of ~$2 Billion in Acquisitions with Meaningful Synergies
Finviz2026-02-26 21:18:42
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 21:21:41
Etsy Q4 2025 Earnings Call Transcript
Finviz2026-02-19 16:48:40
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK in Treating Adults with Head & Neck Cancers
Finviz2026-02-20 12:06:46
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Finviz2026-02-23 21:09:10
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 12:03:58
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Finviz2026-02-24 12:03:57
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
Finviz2026-02-25 12:10:04
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
Finviz2026-02-25 13:03:47
Compared to Projections, The Williams Companies (WMB) Q4 Results: Examining Important Performance Indicators
101 finance2026-02-25 15:34:10
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-26 12:03:47
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
Finviz2026-02-26 12:03:46
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Finviz2026-02-26 21:09:39
Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Finviz2026-02-26 21:06:42
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:09:43
Diversified Energy Reports Record Year, Highlighted by Transformative Year-over-Year Growth, Strong Cash Generation, and Integration of ~$2 Billion in Acquisitions with Meaningful Synergies
Finviz2026-02-26 21:18:42
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 21:21:41
TSE:7508 stock price change
On the last trading day, TSE:7508 stock closed at 1526.00 JPY, with a price change of -2.24% for the day.
Trade stock perpsTSE:7508 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more